Anthropometric Measurements as Predictors of Low Birth Weight Among Tanzanian Neonates: A Hospital-Based Study
November 7, 2025
Brand Name :
Angispan, Vasovin XI, Nitract, Angiplat, Nitroject, Angistat, Nitrogard, Nitroglyn
Synonyms :
glyceryl trinitrate, nitroglycerin
Class :
Anti-anginal agents
Dosage forms and strength Â
Tablet Â
500 mg Â
600 mg  Â
Keep 1 tablet under the tongue and allow it to dissolve slowly
Repeat after 5 minutes if symptoms are not relieved
Pediatric Â
Not determined Â
Drug-Subclass interaction:Â
Antihypertensive agents: an increase in hypotensive effects may be seenÂ
Vasodilators: an increase in hypotensive effects may be seenÂ
Neuroleptics: an increase in hypotensive effects may be seenÂ
TCAs: an increase in hypotensive effects may be seenÂ
MAOIs: an increase in hypotensive effects may be seenÂ
Anticholinergics: the absorption of glyceryl trinitrate may be reducedÂ
Heparin: the anticoagulant effect of heparin can be decreasedÂ
Fatal:Â
Phosphodiesterase type 5 inhibitors: potential hypotensive effects may be seenÂ
Riociguat: potential hypotensive effects may be seenÂ
Actions and spectrum:Â Â
Glyceryl trinitrate produces free nitric oxide radicals. They activate guanylate cyclase and raise guanosine monophosphate (cGMP) in smooth muscle. Â
They dilate coronary arteries and enhance collateral flow to ischemic areas, also lowering cardiac oxygen demand. Â
Frequency not defined Â
Methemoglobinemia Â
Hypoxaemia Â
Vertigo Â
Paradoxical bradycardia Â
Severe hypotension Â
Tachycardia Â
Asthenia Â
Cerebral ischemia Â
Restlessness Â
Syncope Â
Orthostatic hypotension Â
Increase in intracranial pressure Â
Black box warning Â
None Â
Contraindication/Caution:Â Â
Contraindication:Â Â
Increased cranial pressure Â
Extreme bradycardia Â
Severe hypotension Â
Migraine Â
Cautions:Â Â
Lung disease Â
Cerebrovascular disease Â
Hypothyroidism Â
Orthostatic dysfunction Â
Hepatic impairment Â
Renal impairment Â
Pregnancy Warnings:Â
Pregnancy category: N/AÂ
Lactation: Excretion of the drug into the human breast milk is unknownÂ
Pregnancy categories:Â
Category A: Satisfactory and well-controlled studies show no evidence of risk to the fetus in the first trimester or in the later trimester.Â
Category B: No evidence of risk to fetus found in animal reproduction studies and there are not enough studies on pregnant women.Â
Category C: Adverse effects on the fetus found with evidence in animal reproduction studies and no adequate evidence for an effect in humans, care must be taken for potential risks in pregnant women.Â
Category D: There is adequate data available with sufficient evidence of human fetal risk from various platforms, but despite potential risks may be used only in emergency cases for potential benefits.Â
Category X: Drugs listed in this category clearly outweigh risks over benefits. These category drugs should be prohibited for pregnant women.Â
Category N: There is no data available for the drug under this category.Â
Pharmacology:Â Â
Glyceryl trinitrate is known as nitroglycerin. It is an anti-anginal agent used mainly in the treatment of angina pectoris. Â
Pharmacodynamics:Â Â
Glyceryl trinitrate causes vasodilation and decreases preload. It enters vascular smooth muscle and gets converted to nitric oxide thus it leads to the activation of cGMP and vasodilation. Â
Pharmacokinetics:Â
Absorption  Â
It is rapidly absorbed from the sublingual mucosa. Â
Distribution Â
It is widely distributed in the body.  Â
Metabolism Â
It undergoes hepatic metabolism.Â
Elimination and excretion Â
It is eliminated through urinary route.Â
Administration:Â Â
It is taken orally as oral dosage form. Â
Patient information leaflet Â
Generic Name: glyceryl trinitrate Â
Why do we use glyceryl trinitrate? Â
Glyceryl trinitrate is indicated in the treatment of angina pectoris. Â
It is also used to treat myocardial infarction, congestive heart failure and unstable angina.Â